Rapid induction of colorectal tumors in rats initiated with 1,2-dimethylhydrazine followed by dextran sodium sulfate treatment

Cancer Letters

Volumn 198, Issue 2, 2003, Pages 145-152

  Onose, Jun Ichi ^a   Imai, Toshio ^a   Hasumura, Mai ^a   Ueda, Makoto ^a   Hirose, Masao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

1,2 Dimethylhydrazine; Colon carcinogenesis; Dextran sodium sulfate; Rat

Indexed keywords

1,2 DIMETHYLHYDRAZINE; DEXTRAN SULFATE; DRINKING WATER; POLYSACCHARIDE SULFATE; CARCINOGEN;

ADENOCARCINOMA; ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; COLON CARCINOGENESIS; COLORECTAL TUMOR; CONTROLLED STUDY; CRYPT CELL; DISEASE MODEL; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL; ANIMAL; BODY WEIGHT; CANCER STAGING; CHEMICALLY INDUCED DISORDER; COLON TUMOR; DRUG EFFECT; INTESTINE MUCOSA; PATHOLOGY;

1,2-DIMETHYLHYDRAZINE; ADENOCARCINOMA; ANIMALS; BODY WEIGHT; CARCINOGENS; COLONIC NEOPLASMS; DEXTRAN SULFATE; INTESTINAL MUCOSA; NEOPLASM STAGING; RATS;

EID: 0142119398     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00316-1     Document Type: Article

References (29)

1. Bird R. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37:1987;147-151.
2. Bird R. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 93:1995;55-71.
3. McLellan E.A., Medline A., Bird R. Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis. 12:1991;2093-2098.
4. Thorup I., Meyer O., Kristiansen E. Influence of a dietary fiber on development of dimethylhydrazine-induced aberrant crypt foci and colon tumor incidence in Wistar rats. Nutr. Cancer. 21:1994;177-182.
5. Tanaka T., Makita H., Kawabata K., Mori H., Kakumoto M., Satoh K., Hara A., Sumida T., Tanaka T., Ogawa H. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis. 18:1997;957-965.
6. Yamada Y., Yoshimi N., Hirose Y., Matsunaga K., Katayama M., Sakata K., Shimizu M., Kuno T., Mori H. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res. 61:2001;1874-1878.
7. Hirose Y., Kuno T., Yamada Y., Sakata K., Katayama M., Yoshida K., Qiao Z., Hata K., Yoshimi N., Mori H. Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis. 24:2003;107-111.
8. Okayasu I., Yamada M., Mikami T., Yoshida T., Kanno J., Ohkusa T. Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model. J. Gastroenterol. Hepatol. 17:2002;1078-1083.
9. Hirono I., Kuhara K., Hosaka S., Tomizawa S., Golberg L. Induction of intestinal tumors in rats by dextran sulfate sodium. J. Natl Cancer Inst. 66:1981;579-583.
10. Whiteley L.O., Hudson L. Jr., Pretlow T.P. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen. Toxicol. Pathol. 24:1996;681-689.
11. Shibata M., Hirose M., Yamada M., Tatematsu M., Uwagawa S., Ito N. Epithelial cell proliferation in rat forestomach and glandular stomach mucosa induced by catechol and analogous dihydroxybenzenes. Carcinogenesis. 11:1990;997-1000.
12. Obata H., Sawada N., Isomura H., Mori M. Abnormal accumulation of copper in LEC rat liver induces expression of p53 and nuclear matrix-bound p21(waf 1/cip 1). Carcinogenesis. 17:1996;2157-2161.
13. Hard G.C. Mechanisms of chemically induced renal carcinogenesis in the laboratory rodent. Toxicol. Pathol. 26:1998;104-112.
14. Shirai T. A medium-term rat liver bioassay as a rapid in vivo test for carcinogenic potential: a historical review of model development and summary of results from 291 tests. Toxicol. Pathol. 25:1997;453-460.
15. Ou Y.C., Conolly R.B., Thomas R.S., Xu Y., Andersen M.E., Chubb L.S., Pitot H.C., Yang R.S. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay. Cancer Res. 61:(5):2001;1879-1889. Mar 1.
16. Wada S., Hirose M., Shichino Y., Ozaki K., Hoshiya T., Kato K., Shirai T. Effects of catechol, sodium chloride and ethanol either alone or in combination on gastric carcinogenesis in rats pretreated with N-methyl-N′-nitro-N-nitrosoguanidine. Cancer Lett. 123:1998;127-134.
17. Baijal P.K., Clow E.P., Fitzpatrick D.W., Bird R.P. Tumor-enhancing effects of cholic acid are exerted on the early stages of colon carcinogenesis via induction of aberrant crypt foci with an enhanced growth phenotype. Can. J. Physiol. Pharmacol. 76:1998;1095-1102.
18. Tardieu D., Jaeg J.P., Deloly A., Corpet D.E., Cadet J., Petit C.R. The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats. Carcinogenesis. 21:2000;973-976.
19. Berg D.J., Davidson N., Kuhn R., Muller W., Menon S., Holland G., Thompson-Snipes L., Leach M.W., Rennick D. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 98:1996;1010-1020.
20. Okada F., Kawaguchi T., Habelhah H., Kobayashi T., Tazawa H., Takeichi N., Kitagawa T., Hosokawa M. Conversion of human colonic adenoma cells to adenocarcinoma cells through inflammation in nude mice. Lab. Invest. 80:2000;1617-1628.
21. Zheng Y., Kramer P.M., Lubet R.A., Steele V.E., Kelloff G.J., Pereira M.A. Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis. 20:1999;255-260.
22. Kohno H., Yoshitani S., Takashima S., Okumura A., Hosokawa M., Yamaguchi N., Tanaka T. Troglitazone, a ligand for peroxisome proliferator-activated receptor gamma, inhibits chemically-induced aberrant crypt foci in rats. Jpn J. Cancer Res. 92:2001;396-403.
23. Takahashi M., Fukuda K., Sugimura T., Wakabayashi K. Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res. 58:1998;42-46.
24. Shamsuddin A.M., Hogan M.L. Large intestinal carcinogenesis. II. Histogenesis and unusual features of low-dose azoxymethane-induced carcinomas in F344 rats. J. Natl Cancer Inst. 73:1984;1297-1305.
25. Pence B.C., Dunn D.M., Zhao C., Landers M., Wargovich M.J. Chemopreventive effects of calcium but not aspirin supplementation in cholic acid-promoted colon carcinogenesis: correlation with intermediate endpoints. Carcinogenesis. 16:1995;757-765.
26. Davidson L.A., Aymond C.M., Jiang Y.H., Turner N.D., Lupton J.R., Chapkin R.S. Non-invasive detection of fecal protein kinase C beta II and zeta messenger RNA: putative biomarkers for colon cancer. Carcinogenesis. 19:1998;253-257.
27. Reddy B.S., Hirose Y., Lubet R., Steele V., Kelloff G., Paulson S., Seibert K., Rao C.V. Chemoprevention of colon cancer by a specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res. 15:(60):2000;293-297.
28. Mahmoud N.N., Dannenberg A.J., Bilinski R.T., Mestre J.R., Chadburn A., Churchill M., Martucci C., Bertagnolli M.M. Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis. Carcinogenesis. 20:1999;299-303.
29. Rao C.V., Cooma I., Rodriguez J.G., Simi B., El-Bayoumy K., Reddy B.S. Chemoprevention of familial adenomatous polyposis development in the APC(min) mouse model by 1,4-phenylene bis(methylene)selenocyanate. Carcinogenesis. 21:2000;617-621.